Table of Contents

1 Introduction (Page No. - 18)

1.1 Objectives of the Study

1.2 Market Definition

1.3 Market Scope

1.3.1 Markets Covered

1.3.2 Years Considered for the Study

1.4 Currency

1.5 Limitations

1.6 Stakeholders

2 Research Methodology (Page No. - 21)

2.1 Research Data

2.2 Secondary Data

2.2.1 Secondary Sources

2.3 Primary Data

2.4 Market Size Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.4.3 Growth Forecast

2.5 Market Breakdown and Data Triangulation

2.6 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)

4.1 Market Overview

4.2 North American Market, By Drug Type & Country, 2020

4.3 Geographical Snapshot of the Market

5 Market Overview (Page No. - 35)

5.1 Introduction

5.2 Market Dynamics

5.2.1 Drivers

5.2.1.1 Increasing R&D Expenditure in the Pharmaceutical & Biopharmaceutical Industry

5.2.1.2 Globalization of Clinical Trials and Harmonization of Regulations Resulting in the Outsourcing of Clinical Trial Activities

5.2.2 Restraints

5.2.2.1 Increasing Cost of Drug Development and Clinical Trials

5.2.3 Opportunities

5.2.3.1 Patent Expirations

5.2.3.2 Emerging Markets

5.2.3.3 Growth in the Biologics Market

6 Clinical Trial Supplies Market, By Service (Page No. - 41)

6.1 Introduction

6.2 Manufacturing

6.2.1 Manufacturing Services Include Full In-House CGMP Analytical Services, Bioanalytical Services, and Particle Characterization

6.3 Packaging, Labeling, and Blinding

6.3.1 Increasing Demand for Advanced Packaging to Support the Growth of This Market

6.4 Comparator Sourcing

6.4.1 Growing R&D Expenditure in the Pharmaceutical and Biopharmaceutical Industry to Drive Market Growth

6.5 Logistics

6.5.1 Globalization of Clinical Trials has Driven the Demand for Logistics Services

6.6 Distribution, Storage, and Retention

6.6.1 End-To-End Tracking of Drugs is an Important Factor in Clinical Trials

6.7 Solutions

6.7.1 Automation in Drug Discovery and Clinical Trials to Drive Market Growth

7 Clinical Trial Supplies Market, By Phase (Page No. - 47)

7.1 Introduction

7.2 Phase I

7.2.1 Quality of Clinical Trial Supplies and Proper Supply and Distribution Play an Important Role in the Success of a Drug in Phase I Trials

7.3 Phase II

7.3.1 Phase II Trials are Designed to Assess the EffiCACy of Drugs

7.4 Phase III

7.4.1 Involvement of a Large Number of Patients in Phase III Trials�A Major Factor Driving Market Growth

7.5 Phase IV

7.5.1 Phase IV Studies Allow Researchers to Observe the Long-Term Effects of a Particular Drug in a Considerably Larger Pool of Patients

7.6 Ba/Be Studies

7.6.1 Increasing Patent Expiration to Increase the Demand for Ba/Be Studies

8 Clinical Trial Supplies Market, By Drug Type (Page No. - 53)

8.1 Introduction

8.2 Small-Molecule Drugs

8.2.1 Ease of Development of Small-Molecule Drugs to Drive Market Growth

8.3 Biologic Drugs

8.3.1 Increasing Adoption and Affordability of Biologic Drugs to Drive Market Growth

9 Clinical Trial Supplies Market, By Therapeutic Area (Page No. - 56)

9.1 Introduction

9.2 Oncology

9.2.1 High and Growing Number of Research Studies on Cancer Therapeutics to Support Market Growth

9.3 Neurological and Mental Disorders

9.3.1 Increasing Number of Patients Suffering From Neurological Disorders is Driving Market Growth

9.4 Digestive System Diseases

9.4.1 Pharmaceutical Companies are Investing Significantly in R&D for the Development of Innovative Drugs for Digestive System Diseases

9.5 Infectious and Immune System Diseases

9.5.1 Emergence of New Infectious Diseases to Drive Market Growth

9.6 Blood Disorders

9.6.1 High Global Burden of Blood Disorders has Increased the Focus on Developing Effective Drugs

9.7 Other Therapeutic Areas

10 Clinical Trial Supplies Market, By Region (Page No. - 64)

10.1 Introduction

10.2 North America

10.2.1 US

10.2.1.1 Availability of Advanced R&D Infrastructure has Driven the Growth of the US Market

10.2.2 Canada

10.2.2.1 Preference of Pharmaceutical Companies to Conduct Clinical Trials in Canada to Support Market Growth

10.3 Europe

10.3.1 Germany

10.3.1.1 Germany Accounted for the Largest Share of the European Market

10.3.2 UK

10.3.2.1 Favorable Government Initiatives in the UK to Support Market Growth

10.3.3 France

10.3.3.1 High Number of Oncology Clinical Trials in France to Drive Market Growth

10.3.4 Italy

10.3.4.1 High Number of Clinical Trials and the Low Drug Approval Time are the Major Factors Driving Market Growth

10.3.5 Spain

10.3.5.1 Short Study Start-Up Times and Rising R&D Expenditure to Boost the Growth of the Spanish Market

10.3.6 Rest of Europe

10.4 Asia Pacific

10.4.1 China

10.4.1.1 Low Cost of Clinical Trials and Large Pharmaceutical R&D Footprint in China to Drive Market Growth

10.4.2 India

10.4.2.1 Low-Cost Services and Availability of Skilled Workforce to Support Market Growth in India

10.4.3 Japan

10.4.3.1 Government Initiatives for Drug Innovation to Support Market Growth in Japan

10.4.4 Australia

10.4.4.1 Low Cost of Conducting Clinical Trials to Support Market Growth in Australia

10.4.5 Singapore

10.4.5.1 Increasing Focus of Various Companies on Singapore to Support Market Growth

10.4.6 South Korea

10.4.6.1 Government Support for Drug Innovation to Support Market Growth in South Korea

10.4.7 Rest of Asia Pacific

10.5 Rest of the World

10.5.1 Brazil

10.5.2 Mexico

10.5.3 Other RoW Countries

11 Competitive Landscape (Page No. - 116)

11.1 Overview

11.2 Market Share Analysis, 2018

11.3 Competitive Scenario

11.3.1 Service Launches

11.3.2 Agreements and Collaborations

11.3.3 Acquisitions

11.3.4 Expansions

11.3.5 Other Developments

11.4 Competitive Leadership Mapping (2019)

11.4.1 Vendor Inclusion Criteria

11.4.2 Visionary Leaders

11.4.3 Innovators

11.4.4 Dynamic Differentiators

11.4.5 Emerging Companies

12 Company Profiles (Page No. - 122)

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

12.1 Catalent, Inc.

12.2 Almac Group

12.3 Parexel International Corporation

12.4 Thermo Fisher Scientific, Inc.

12.5 PCI Services

12.6 UDG Healthcare PLC.

12.7 Biocair

12.8 Bilcare Limited

12.9 O&M Movianto (Part of Owens & Minor)

12.10 KLIFO A/S

12.11 Capsugel (Part of Lonza Group)

12.12 Infosys Limited

12.13 PRA Health Sciences, Inc.

12.14 Eurofins Scientific

12.15 Marken (A Subsidiary of UPS)

12.16 Seveillar Clinical Trial Supplies Pvt. Ltd.

12.17 N-Side

12.18 Metrics Contract Services

12.19 SIRO Clinpharm Pvt. Ltd.

12.20 CSM- Clingen Company

*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 153)

13.1 Discussion Guide

13.2 Knowledge Store: Marketsandmarkets� Subscription Portal

13.3 Available Customizations

13.4 Related Reports



List of Tables (132 Tables)

Table 1 Pharmaceutical R&D Spending, By Company, 2018

Table 2 Global Cancer Incidence, 2018 Vs. 2025

Table 3 Global Incidence of the Top 10 Fatal Diseases, 2015�2017 (Million)

Table 4 Average Cost of Drugs Approved Per Year, 2004�2013

Table 5 Clinical Trial Supplies Market, By Service, 2018�2025 (USD Million)

Table 6 Market for Manufacturing Services, By Region, 2018�2025 (USD Million)

Table 7 Market for Packaging, Labeling, and Blinding Services, By Region, 2018�2025 (USD Million)

Table 8 Market for Comparator Sourcing Services, By Region, 2018�2025 (USD Million)

Table 9 Market for Logistics Services, By Region, 2018�2025 (USD Million)

Table 10 Clinical Trial Supplies Market for Distribution, Storage, and Retention Services, By Region, 2018�2025 (USD Million)

Table 11 Market for Solutions, By Region, 2018�2025 (USD Million)

Table 12 Market, By Phase, 2018�2025 (USD Million)

Table 13 Market for Phase I Trials, By Region, 2018�2025 (USD Million)

Table 14 Clinical Trial Supplies Market for Phase II Trials, By Region, 2018�2025 (USD Million)

Table 15 Market for Phase III Trials, By Region, 2018�2025 (USD Million)

Table 16 Market for Phase IV Trials, By Region, 2018�2025 (USD Million)

Table 17 Market for Ba/Be Studies, By Region, 2018�2025 (USD Million)

Table 18 Market, By Drug Type, 2018�2025 (USD Million)

Table 19 Market for Small-Molecule Drugs, By Region, 2018�2025 (USD Million)

Table 20 Market for Biologic Drugs, By Region, 2018�2025 (USD Million)

Table 21 Global Number of Clinical Trials, By Therapeutic Area (As of October 2019)

Table 22 Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 23 Clinical Trial Supplies Market for Oncology, By Region, 2018�2025 (USD Million)

Table 24 Market for Neurological and Mental Disorders, By Region, 2018�2025 (USD Million)

Table 25 Market for Digestive System Diseases, By Region, 2018�2025 (USD Million)

Table 26 Market for Infectious and Immune System Diseases, By Region, 2018�2025 (USD Million)

Table 27 Market for Blood Disorders, By Region, 2018�2025 (USD Million)

Table 28 Market for Other Therapeutic Areas, By Region, 2018�2025 (USD Million)

Table 29 Market, By Region, 2018�2025 (USD Million)

Table 30 North America: Market, By Country, 2018�2025 (USD Million)

Table 31 North America: Clinical Trial Supplies Market, By Service, 2018�2025 (USD Million)

Table 32 North America: Market, By Phase, 2018�2025 (USD Million)

Table 33 North America: Market, By Drug Type, 2018�2025 (USD Million)

Table 34 North America: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 35 Number of Clinical Trials Started in the US, By Company, 2017

Table 36 US: Market, By Service, 2018�2025 (USD Million)

Table 37 US: Market, By Phase, 2018�2025 (USD Million)

Table 38 US: Market, By Drug Type, 2018�2025 (USD Million)

Table 39 US: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 40 Number of Active Clinical Trials in Canada, By Condition (2019)

Table 41 Number of Active Clinical Trials in Canada, By Company, 2017

Table 42 Canada: Clinical Trial Supplies Market, By Service, 2018�2025 (USD Million)

Table 43 Canada: Market, By Phase, 2018�2025 (USD Million)

Table 44 Canada: Market, By Drug Type, 2018�2025 (USD Million)

Table 45 Canada: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 46 Europe: Market, By Country, 2018�2025 (USD Million)

Table 47 Europe: Market, By Service, 2018�2025 (USD Million)

Table 48 Europe: Market, By Phase, 2018�2025 (USD Million)

Table 49 Europe: Market, By Drug Type, 2018�2025 (USD Million)

Table 50 Europe: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 51 Germany: upplies Market, By Service, 2018�2025 (USD Million)

Table 52 Germany: Market, By Phase, 2018�2025 (USD Million)

Table 53 Germany: Market, By Drug Type, 2018�2025 (USD Million)

Table 54 Germany: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 55 UK: Market, By Service, 2018�2025 (USD Million)

Table 56 UK: Market, By Phase, 2018�2025 (USD Million)

Table 57 UK: Market, By Drug Type, 2018�2025 (USD Million)

Table 58 UK: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 59 Number of Clinical Trials Started in France, By Company, 2017

Table 60 France: Market, By Service, 2018�2025 (USD Million)

Table 61 France: Market, By Phase, 2018�2025 (USD Million)

Table 62 France: Market, By Drug Type, 2018�2025 (USD Million)

Table 63 France: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 64 Number of Clinical Trials Started in Italy, By Company, 2017

Table 65 Italy: Clinical Trial Supplies Market, By Service, 2018�2025 (USD Million)

Table 66 Italy: Market, By Phase, 2018�2025 (USD Million)

Table 67 Italy: Market, By Drug Type, 2018�2025 (USD Million)

Table 68 Italy: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 69 Spain: Market, By Service, 2018�2025 (USD Million)

Table 70 Spain: Market, By Phase, 2018�2025 (USD Million)

Table 71 Spain: Market, By Drug Type, 2018�2025 (USD Million)

Table 72 Spain: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 73 RoE: Market, By Service, 2018�2025 (USD Million)

Table 74 RoE: Clinical Trial Supplies Market, By Phase, 2018�2025 (USD Million)

Table 75 RoE: Market, By Drug Type, 2018�2025 (USD Million)

Table 76 RoE: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 77 Total Number of Clinical Trials in APAC, By Therapeutic Area, 2017

Table 78 APAC: Market, By Country, 2018�2025 (USD Million)

Table 79 APAC: Market, By Service, 2018�2025 (USD Million)

Table 80 APAC: Market, By Phase, 2018�2025 (USD Million)

Table 81 APAC: Market, By Drug Type, 2018�2025 (USD Million)

Table 82 APAC: Clinical Trial Supplies Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 83 China: Market, By Service, 2018�2025 (USD Million)

Table 84 China: Market, By Phase, 2018�2025 (USD Million)

Table 85 China: Market, By Drug Type, 2018�2025 (USD Million)

Table 86 China: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 87 India: Market, By Service, 2018�2025 (USD Million)

Table 88 India: Market, By Phase, 2018�2025 (USD Million)

Table 89 India: Market, By Drug Type, 2018�2025 (USD Million)

Table 90 India: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 91 Japan: Clinical Trial Supplies Market, By Service, 2018�2025 (USD Million)

Table 92 Japan: Market, By Phase, 2018�2025 (USD Million)

Table 93 Japan: Market, By Drug Type, 2018�2025 (USD Million)

Table 94 Japan: Clinical Trial Supplies Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 95 Australia: Market, By Service, 2018�2025 (USD Million)

Table 96 Australia: Market, By Phase, 2018�2025 (USD Million)

Table 97 Australia: Market, By Drug Type, 2018�2025 (USD Million)

Table 98 Australia: Clinical Trial Supplies Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 99 Singapore: Market, By Service, 2018�2025 (USD Million)

Table 100 Singapore: Market, By Phase, 2018�2025 (USD Million)

Table 101 Singapore: Market, By Drug Type, 2018�2025 (USD Million)

Table 102 Singapore: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 103 South Korea: Market, By Service, 2018�2025 (USD Million)

Table 104 South Korea: Market, By Phase, 2018�2025 (USD Million)

Table 105 South Korea: Clinical Trial Supplies Market, By Drug Type, 2018�2025 (USD Million)

Table 106 South Korea: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 107 RoAPAC: Market, By Service, 2018�2025 (USD Million)

Table 108 RoAPAC: Market, By Phase, 2018�2025 (USD Million)

Table 109 RoAPAC: Market, By Drug Type, 2018�2025 (USD Million)

Table 110 RoAPAC: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 111 RoW: Market, By Country, 2018�2025 (USD Million)

Table 112 RoW: Market, By Service, 2018�2025 (USD Million)

Table 113 RoW: Market, By Phase, 2018�2025 (USD Million)

Table 114 RoW: Market, By Drug Type, 2018�2025 (USD Million)

Table 115 RoW: Clinical Trial Supplies Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 116 Brazil: Market, By Service, 2018�2025 (USD Million)

Table 117 Brazil: Market, By Phase, 2018�2025 (USD Million)

Table 118 Brazil: Market, By Drug Type, 2018�2025 (USD Million)

Table 119 Brazil: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 120 Mexico: Market, By Service, 2018�2025 (USD Million)

Table 121 Mexico: Market, By Phase, 2018�2025 (USD Million)

Table 122 Mexico: Market, By Drug Type, 2018�2025 (USD Million)

Table 123 Mexico: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 124 Other RoW Countries: Market, By Service, 2018�2025 (USD Million)

Table 125 Other RoW Countries: Market, By Phase, 2018�2025 (USD Million)

Table 126 Other RoW Countries: Market, By Drug Type, 2018�2025 (USD Million)

Table 127 Other RoW Countries: Market, By Therapeutic Area, 2018�2025 (USD Million)

Table 128 Service Launches, 2017�2019

Table 129 Agreements & Collaborations, 2017�2019

Table 130 Acquisitions, 2017�2019

Table 131 Expansions, 2017�2019

Table 132 Other Developments, 2017�2019





List of Figures (37 Figures)



Figure 1 Research Design

Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region

Figure 3 Market Size Estimation: Bottom-Up Approach

Figure 4 Market Size Estimation: Top-Down Approach

Figure 5 Data Triangulation Methodology

Figure 6 Clinical Trial Supplies Market, By Service, 2020 Vs. 2025 (USD Million)

Figure 7 Market, By Phase, 2020 Vs. 2025 (USD Million)

Figure 8 Market, By Drug Type, 2020 Vs. 2025 (USD Million)

Figure 9 Market, By Therapeutic Area, 2020 Vs. 2025 (USD Million)

Figure 10 Market, By Region, 2020 Vs. 2025 (USD Million)

Figure 11 Increasing R&D Expenditure in Pharma and Biotech Industries to Drive Market Growth

Figure 12 Small-Molecule Drugs Segment to Account for the Largest Market Share in 2020

Figure 13 China to Register the Highest Growth During the Forecast Period

Figure 14 Market: Drivers, Restraints, and Opportunities

Figure 15 R&D Spending By Phrma Member-Companies, 2001�2017 (USD Billion)

Figure 16 Number of Registered Clinical Trial Studies (Global), 2011�2018

Figure 17 Average Cost of Developing One New Approved Drug�Including the Cost of Failures

Figure 18 R&D Pipeline, By Therapy Group, 2018 & 2019

Figure 19 Total Number of Clinical Trials for Oncology, By Region (As of December 2019)

Figure 20 Total Number of Clinical Trials: Global Vs. North America

Figure 21 North America: Clinical Trial Supplies Market Snapshot

Figure 22 US: Pipeline Split of Pharma/Biotech Companies, By Phase (January 2019)

Figure 23 Number of Clinical Trials Conducted in Europe, By Country, 2018

Figure 24 Spain: Pharmaceutical R&D Expenditure, 2011�2017

Figure 25 APAC: Market Snapshot

Figure 26 Key Developments in the Market, 2017�2019

Figure 27 Global Market Share Analysis, 2018

Figure 28 Catalent, Inc.: Company Snapshot (2018)

Figure 29 Thermo Fisher Scientific, Inc.: Company Snapshot (2018)

Figure 30 UDG Healthcare: Company Snapshot (2018)

Figure 31 Bilcare Limited: Company Snapshot (2018)

Figure 32 Owens & Minor: Company Snapshot (2018)

Figure 33 Lonza Group: Company Snapshot (2018)

Figure 34 Infosys Limited: Company Snapshot (2018)

Figure 35 PRA Health Sciences, Inc.: Company Snapshot (2018)

Figure 36 Eurofins Scientific: Company Snapshot (2018)

Figure 37 UPS, Inc.: Company Snapshot (2018)